Common Stock, Shares, Outstanding of Oncotelic Therapeutics, Inc. from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Oncotelic Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • Oncotelic Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 439,446,318, a 7.9% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Oncotelic Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 439,446,318 +32,156,700 +7.9% 30 Sep 2025 10-Q 17 Nov 2025 2025 Q3
Q2 2025 408,292,720 +1,003,102 +0.25% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 408,292,720 +8,608,592 +2.2% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 407,289,618 +8,105,490 +2% 31 Dec 2024 10-Q 17 Nov 2025 2025 Q3
Q3 2024 407,289,618 +9,130,490 +2.3% 30 Sep 2024 10-Q 19 Nov 2024 2024 Q3
Q2 2024 407,289,618 +9,758,028 +2.5% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 399,684,128 +6,812,248 +1.7% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 399,184,128 +7,337,248 +1.9% 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q3 2023 398,159,128 +7,963,695 +2% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 397,531,590 +11,489,728 +3% 30 Jun 2023 10-Q 18 Aug 2023 2023 Q2
Q1 2023 392,871,880 +14,241,776 +3.8% 31 Mar 2023 10-Q 22 May 2023 2023 Q1
Q4 2022 391,846,880 +16,558,734 +4.4% 31 Dec 2022 10-K 12 Apr 2024 2023 FY
Q3 2022 390,195,433 +17,630,522 +4.7% 30 Sep 2022 10-Q 18 Nov 2022 2022 Q3
Q2 2022 386,041,862 +15,944,903 +4.3% 30 Jun 2022 10-Q 22 Aug 2022 2022 Q2
Q1 2022 378,630,104 +9,183,145 +2.5% 31 Mar 2022 10-Q 23 May 2022 2022 Q1
Q4 2021 375,288,146 +284,686,234 +314% 31 Dec 2021 10-K/A 20 Apr 2023 2022 FY
Q3 2021 372,564,911 +282,962,999 +316% 30 Sep 2021 10-Q 22 Nov 2021 2021 Q3
Q2 2021 370,096,959 +281,495,047 +318% 30 Jun 2021 10-Q 20 Aug 2021 2021 Q2
Q1 2021 369,446,959 +281,414,847 +320% 31 Mar 2021 10-Q 24 May 2021 2021 Q1
Q4 2020 90,601,912 +6,531,945 +7.8% 31 Dec 2020 10-K 15 Apr 2022 2021 FY
Q3 2020 89,601,912 +6,131,945 +7.3% 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 88,601,912 +5,131,945 +6.1% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 88,032,112 +46,612,112 +113% 31 Mar 2020 10-Q 29 Jun 2020 2020 Q1
Q4 2019 84,069,967 +77,226,165 +1128% 31 Dec 2019 10-K 15 Apr 2021 2020 FY
Q3 2019 83,469,967 +42,049,967 +102% 30 Sep 2019 10-Q 19 Nov 2019 2019 Q3
Q2 2019 83,469,967 +42,049,967 +102% 30 Jun 2019 10-Q 19 Aug 2019 2019 Q2
Q1 2019 41,420,000 +14,875,000 +56% 31 Mar 2019 10-Q 15 May 2019 2019 Q1
Q4 2018 6,843,802 -19,701,198 -74% 31 Dec 2018 10-K 14 May 2020 2019 FY
Q3 2018 41,420,000 +14,875,000 +56% 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 41,420,000 +14,875,000 +56% 30 Jun 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 26,545,000 0 0% 31 Mar 2018 10-Q 14 May 2018 2018 Q1
Q4 2017 26,545,000 0 0% 31 Dec 2017 10-K 10 Apr 2019 2018 FY
Q3 2017 26,545,000 0 0% 30 Sep 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 26,545,000 0 0% 30 Jun 2017 10-Q 02 Aug 2017 2017 Q2
Q1 2017 26,545,000 0 0% 31 Mar 2017 10-Q 08 May 2017 2017 Q1
Q4 2016 26,545,000 0 0% 31 Dec 2016 10-K 17 Apr 2018 2017 FY
Q3 2016 26,545,000 0 0% 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 26,545,000 0 0% 30 Jun 2016 10-Q 02 Aug 2016 2016 Q2
Q1 2016 26,545,000 0 0% 31 Mar 2016 10-Q 06 May 2016 2016 Q1
Q4 2015 26,545,000 +5,840,000 +28% 31 Dec 2015 10-K 30 Mar 2017 2016 FY
Q3 2015 26,545,000 +5,839,000 +28% 30 Sep 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 26,545,000 +5,843,000 +28% 30 Jun 2015 10-Q 06 Aug 2015 2015 Q2
Q1 2015 26,545,000 +11,251,000 +74% 31 Mar 2015 10-Q 07 May 2015 2015 Q1
Q4 2014 20,705,000 +15,119,000 +271% 31 Dec 2014 10-K 25 Mar 2016 2015 FY
Q3 2014 20,706,000 +17,707,000 +590% 30 Sep 2014 10-Q 13 Nov 2014 2014 Q3
Q2 2014 20,702,000 +18,428,000 +810% 30 Jun 2014 10-Q 08 Aug 2014 2014 Q2
Q1 2014 15,294,000 +13,219,000 +637% 31 Mar 2014 10-Q 08 May 2014 2014 Q1
Q4 2013 5,586,000 +3,840,000 +220% 31 Dec 2013 10-K 30 Mar 2015 2014 FY
Q3 2013 2,999,000 -16,765,000 -85% 30 Sep 2013 10-Q 13 Nov 2013 2013 Q3
Q2 2013 2,274,000 -15,274,000 -87% 30 Jun 2013 10-Q/A 18 Oct 2013 2013 Q2
Q1 2013 2,075,000 -14,096,000 -87% 31 Mar 2013 10-Q 09 May 2013 2013 Q1
Q4 2012 1,746,000 +481,000 +38% 31 Dec 2012 10-K 20 Mar 2014 2013 FY
Q3 2012 19,764,000 +4,993,000 +34% 30 Sep 2012 10-Q 09 Nov 2012 2012 Q3
Q2 2012 17,548,000 +5,861,000 +50% 30 Jun 2012 10-Q 13 Aug 2012 2012 Q2
Q1 2012 16,171,000 31 Mar 2012 10-Q 11 May 2012 2012 Q1
Q4 2011 1,265,000 -4,236,000 -77% 31 Dec 2011 10-K 15 Mar 2013 2012 FY
Q3 2011 14,771,000 30 Sep 2011 10-Q 10 Nov 2011 2011 Q3
Q2 2011 11,687,000 30 Jun 2011 10-Q 12 Aug 2011 2011 Q2
Q4 2010 5,501,000 31 Dec 2010 10-K 28 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.